Aclarion, Inc. (ACON) Documents: SEC Filings, Investor Presentations & Press Releases
Aclarion, Inc. (ACON) documents, SEC filings and the IR site together: 115 documents, newest first; latest 2026-08-06. Read in-app with summaries. First-party data.
Documents — U.S. SEC EDGAR and the company's IR site| Date | Type | Document |
|---|
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-29 | Deck | Aclarion Corporate Overview |
| 2026-06-04 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-13 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-30 | Press release | Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption |
| 2026-04-27 | Proxy | Definitive proxy statement |
| 2026-04-22 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-19 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-18 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-13 | 8-K | Form 8-K, Item 7.01 |
| 2026-01-09 | 8-K | Form 8-K, Item 1.01 |
| 2025-11-12 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-14 | 8-K | Form 8-K, Item 1.01 |
| 2025-09-03 | 8-K | Form 8-K, Item 1.01 |
| 2025-08-14 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-07-21 | 8-K | Form 8-K, Item 5.07 |
| 2025-07-07 | 8-K | Form 8-K, Item 5.07 |
| 2025-06-20 | 8-K | Form 8-K, Item 5.02 |
| 2025-05-15 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-05-13 | Proxy | Definitive proxy statement |
| 2025-04-23 | 8-K | Form 8-K, Item 7.01 |
| 2025-04-09 | 10-K | Annual report on Form 10-K, FY24 |
| 2025-03-28 | 8-K | Form 8-K, Item 3.03 |
| 2025-03-13 | 8-K | Form 8-K, Item 8.01 |
| 2025-03-06 | 8-K | Form 8-K, Item 5.07 |
| 2025-02-28 | 8-K | Form 8-K, Item 5.07 |
| 2025-02-03 | Proxy | Definitive proxy statement |
| 2025-01-31 | 8-K | Form 8-K, Item 1.01 |
| 2025-01-30 | 8-K | Form 8-K, Item 3.03 |
| 2025-01-17 | 8-K | Form 8-K, Item 1.01 |
| 2025-01-10 | SEC filing | Form S-1/A |
| 2025-01-06 | 8-K | Form 8-K, Item 1.01 |
| 2025-01-03 | 8-K | Form 8-K, Item 5.07 |
| 2025-01-03 | 8-K | Form 8-K, Item 1.02 |
| 2024-12-26 | SEC filing | Form S-1/A |
| 2024-12-11 | SEC filing | Form S-1 |
| 2024-12-02 | Proxy | Definitive proxy statement |
| 2024-11-27 | 8-K | Form 8-K, Item 1.01 |
| 2024-11-14 | Press release | Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st |
| 2024-11-14 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
ACON overview · ACON earnings · ACON financials · ACON KPIs · ACON ownership · ACON peers
Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.